The Journal of Psychopharmacology is an academic journal dedicated to the field of psychopharmacology, covering both basic and clinical research on psychotropic drugs. This magazine provides a platform for medical professionals to exchange the latest research findings and academic insights, including original research, reviews, case reports, as well as clinical and preclinical studies. The magazine pays special attention to the drug treatment of major mental illnesses, such as the efficacy and side effects of antipsychotics, mood stabilizers, and antidepressants, as well as exploring new drug targets and neural circuits.

The magazine encourages the use of biological markers, such as genetic markers, structural and functional imaging, neurocognitive function, etc., to evaluate drug efficacy. At the same time, attention is also paid to the research of individualized treatment plans, as well as drug research targeting inflammation and immunity, as these may play a certain role in the pathogenesis of mental illnesses. In addition, the magazine emphasizes the importance of precision medicine, especially in the fields of therapeutic drug monitoring and pharmacogenomics.